VTGN: the cash flow

MyFinsight

The latest financial statement is for the quarter ending 2025-12-31.

Cash Flow	2025-12-31	2025-09-30	2025-06-30
Net loss	-18,899	-19,417	-15,095
Depreciation and amortization	54	53	40
Stock-based compensation	1,096	1,096	916
Amortization of operating lease right-of-use asset	135	132	129
Non-cash interest expense	-1	-1	3
Accretion on marketable securities	-142	-145	-125
Prepaid expenses and other current assets	-284	-1,777	1,942
Other assets	9	0	37
Operating lease liability	-159	-216	-86
Deferred revenue, net of deferred contract acquisition costs	-284	-239	-225
Accounts payable and accrued expenses	294	3,201	-2,424
Net cash used in operating activities	-17,631	-13,759	-18,846
Purchases of laboratory and other equipment	26	60	65
Sales and maturities of marketable securities	6,000	2,000	8,000
Purchases of marketable securities	5,870	2,034	8,723
Net cash used in investing activities	104	-94	-788
Net proceeds from sale of common stock under open market sale agreement, net of offering costs	2,313	27,928	397
Net proceeds from sale of common stock under 2019 employee stock purchase plan	70	0	161
Issuance of note payable for insurance policy	0	0	1,020
Net proceeds from option exercises	7	-	-
Repayment of notes payable	278	274	90
Net cash provided by financing activities	2,112	27,654	1,488
Net change in cash and cash equivalents	-15,415	13,801	-18,146
Cash and cash equivalents at beginning of period	62,786	67,131	-
Cash and cash equivalents at end of period	47,371	62,786	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.